Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease
pharmaceutical investing Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease
SAGA Metals Reports Assays from R-0018 to R-0020 with Intercepts Including 49.51% Fe?O?, 6.56% TiO?, 0.374% V?O? from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
Sirios Resources Inc. Closes Fully-Subscribed $25 Million Brokered LIFE Offering of Flow-Through Units and Units
RZOLV Reports Preliminary Bench-Scale Silver Recovery Results on Solar Panel Concentrate, Highlighting Opportunity for High-Value PV Recycling
